ALLR
Allarity Therapeutics, Inc.NASDAQHealthcare$1.18+1.72%ClosedMarket Cap: $19.0M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
1.66
P/S
59.30
EV/EBITDA
-0.40
DCF Value
$10.33
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
-3939.1%
Net Margin
0.0%
ROE
0.0%
ROA
0.0%
ROIC
-128.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $320.0K | 0.0% | $-2.9M | $7.9M | $0.59 | — |
| FY 2025 | $320.0K | 0.0% | $-12.6M | $-11.2M | $0.00 | — |
| Q3 2025 | $0.00 | NaN% | $-2.5M | $-2.8M | $-0.19 | — |
| Q2 2025 | $0.00 | NaN% | $-4.1M | $-2.3M | $-0.15 | — |
| Q1 2025 | $0.00 | NaN% | $-3.0M | $-2.7M | $-0.25 | — |
| Q4 2024 | $0.00 | NaN% | $-7.3M | $-7.5M | $-1.02 | — |
| FY 2024 | $0.00 | NaN% | $-27.2M | $-24.5M | $-15.79 | — |
| Q3 2024 | $0.00 | NaN% | $-12.3M | $-11.6M | $-7.71 | — |
| Q2 2024 | $0.00 | NaN% | $-3.4M | $-1.6M | $-3.40 | — |
| Q1 2024 | $0.00 | NaN% | $-4.2M | $-3.8M | $-20,905.00 | — |
| Q4 2023 | $0.00 | NaN% | $-4.9M | $-1.7M | $-175.51 | — |
| FY 2023 | $0.00 | -Infinity% | $-17.1M | $-11.9M | $-6,031.31 | — |